SCN2A mutations and benign familial neonatal-infantile seizures: the phenotypic spectrum

Epilepsia. 2007 Jun;48(6):1138-42. doi: 10.1111/j.1528-1167.2007.01049.x. Epub 2007 Mar 26.


Mutations of the sodium channel subunit gene SCN2A have been described in families with benign familial neonatal-infantile seizure (BFNIS). We describe two large families with BFNIS and novel SCN2A mutations. The families had 12 and 9 affected individuals, respectively, with phenotypes consistent with BFNIS. Two mutations were discovered in SCN2A (E430Q; I1596S). Both families had individuals with neonatal onset but the typical age of onset was in the early infantile period (mean 3.0 months). One mutation positive individual, with an otherwise typical clinical pattern, had seizures beginning at 13 months. Two individuals with SCN2A mutations were identified with seizures in later life. In each family a single individual with infantile seizures was mutation negative and thus represented phenocopies. This study extends the age range of presentation of BFNIS, confirms that neonatal and early infantile onsets are characteristic, and emphasizes the role of molecular diagnosis to confirm the etiology.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Age of Onset
  • Aged
  • Aged, 80 and over
  • Australia / epidemiology
  • Child
  • DNA Mutational Analysis
  • Electroencephalography / statistics & numerical data
  • Epilepsy, Benign Neonatal / diagnosis
  • Epilepsy, Benign Neonatal / epidemiology
  • Epilepsy, Benign Neonatal / genetics*
  • Family
  • Genetic Carrier Screening
  • Humans
  • Infant
  • Middle Aged
  • Mutation / genetics*
  • NAV1.2 Voltage-Gated Sodium Channel
  • Nerve Tissue Proteins / genetics*
  • Pedigree
  • Phenotype
  • Sodium Channels / genetics*
  • Sweden / epidemiology


  • NAV1.2 Voltage-Gated Sodium Channel
  • Nerve Tissue Proteins
  • SCN2A protein, human
  • Sodium Channels